Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-04-28 | Roivant Sciences Ltd. | Pulik Richard
(CFO) |
F | Common Shares | D | 2340 | $11.03 - $11.03 | $25,810 |
2024-04-24 | Roivant Sciences Ltd. | Fitzgerald Meghan
(Director) |
F | Common Shares | D | 83 | $10.90 - $10.90 | $904 |
2024-04-24 | Roivant Sciences Ltd. | Fitzgerald Meghan
(Director) |
A | Common Shares | A | 1261 | $0.00 - $0.00 | $0 |
2024-04-24 | Roivant Sciences Ltd. | MOMTAZEE JAMES C
(Director) |
F | Common Shares | D | 293 | $10.90 - $10.90 | $3,193 |
2024-04-24 | Roivant Sciences Ltd. | MOMTAZEE JAMES C
(Director) |
A | Common Shares | A | 1490 | $0.00 - $0.00 | $0 |
2024-04-24 | Roivant Sciences Ltd. | Oren Ilan
(Director) |
F | Common Shares | D | 54 | $10.90 - $10.90 | $588 |
2024-04-24 | Roivant Sciences Ltd. | Oren Ilan
(Director) |
A | Common Shares | A | 2121 | $0.00 - $0.00 | $0 |
2024-04-24 | Roivant Sciences Ltd. | Epperly Melissa B,
(Director) |
F | Common Shares | D | 123 | $10.90 - $10.90 | $1,340 |
2024-04-24 | Roivant Sciences Ltd. | Epperly Melissa B,
(Director) |
A | Common Shares | A | 1146 | $0.00 - $0.00 | $0 |
2024-04-22 | Roivant Sciences Ltd. | Kumar Rakhi
(Chief Accounting Officer) |
A | Common Shares | D | 38685 | $0.00 - $0.00 | $0 |
2024-04-22 | Roivant Sciences Ltd. | Pulik Richard
(CFO) |
A | Common Shares | A | 38685 | $0.00 - $0.00 | $0 |
2024-04-20 | Roivant Sciences Ltd. | Gline Matthew
(CEO) |
F | Common Shares | D | 10945 | $10.46 - $10.46 | $114,484 |
2024-04-20 | Roivant Sciences Ltd. | Pulik Richard
(CFO) |
F | Common Shares | D | 8515 | $10.46 - $10.46 | $89,066 |
2024-04-20 | Roivant Sciences Ltd. | Kumar Rakhi
(Chief Accounting Officer) |
F | Common Shares | D | 9881 | $10.46 - $10.46 | $103,355 |
2024-04-20 | Roivant Sciences Ltd. | Venker Eric
(President & COO) |
F | Common Shares | D | 16002 | $10.46 - $10.46 | $167,380 |
2024-03-28 | Roivant Sciences Ltd. | Pulik Richard
(CFO) |
F | Common Shares | D | 2341 | $10.54 - $10.54 | $24,674 |
2024-03-30 | Roivant Sciences Ltd. | Sukhatme Mayukh
(Pres&Chief Investment Officer) |
F | Common Shares | D | 366211 | $10.54 - $10.54 | $3,859,863 |
2024-03-30 | Roivant Sciences Ltd. | Gline Matthew
(CEO) |
F | Common Shares | D | 215991 | $10.54 - $10.54 | $2,276,545 |
2024-03-20 | Roivant Sciences Ltd. | Venker Eric
(President & COO) |
F | Common Shares | D | 16003 | $10.01 - $10.01 | $160,190 |
2024-03-20 | Roivant Sciences Ltd. | Kumar Rakhi
(Chief Accounting Officer) |
F | Common Shares | D | 1506 | $10.01 - $10.01 | $15,075 |
2024-03-20 | Roivant Sciences Ltd. | Gline Matthew
(CEO) |
F | Common Shares | D | 10945 | $10.01 - $10.01 | $109,559 |
2024-03-07 | Roivant Sciences Ltd. | MANCHESTER KEITH S
(Director) |
J | Common Shares | D | 30257723 | $0.00 - $0.00 | $0 |
2024-03-07 | Roivant Sciences Ltd. | Gold Daniel Allen
(Director) |
J | Common Shares | D | 45821757 | $0.00 - $0.00 | $0 |
2024-03-07 | Roivant Sciences Ltd. | QVT Financial LP
(AtLeastTenPercentOwner) |
J | Common Shares | D | 45821757 | $0.00 - $0.00 | $0 |
2024-02-28 | Roivant Sciences Ltd. | Pulik Richard
(CFO) |
F | Common Shares | D | 1630 | $11.71 - $11.71 | $19,087 |
2024-02-20 | Roivant Sciences Ltd. | Kumar Rakhi
(Chief Accounting Officer) |
F | Common Shares | D | 1508 | $11.54 - $11.54 | $17,402 |
2024-02-20 | Roivant Sciences Ltd. | Venker Eric
(President & COO) |
F | Common Shares | D | 16002 | $11.54 - $11.54 | $184,663 |
2024-02-20 | Roivant Sciences Ltd. | Gline Matthew
(CEO) |
F | Common Shares | D | 10945 | $11.54 - $11.54 | $126,305 |
2024-02-09 | Roivant Sciences Ltd. | Venker Eric
(President & COO) |
S | Common Shares | D | 96950 | $10.92 - $10.92 | $1,058,694 |
2024-02-09 | Roivant Sciences Ltd. | Venker Eric
(President & COO) |
M | Common Shares | A | 96950 | $3.85 - $3.85 | $373,257 |
2024-01-28 | Roivant Sciences Ltd. | Pulik Richard
(CFO) |
F | Common Shares | D | 1896 | $10.37 - $10.37 | $19,661 |
2024-01-19 | Roivant Sciences Ltd. | MOMTAZEE JAMES C
(Director) |
A | Common Shares | A | 1570 | $0.00 - $0.00 | $0 |
2024-01-19 | Roivant Sciences Ltd. | Fitzgerald Meghan
(Director) |
A | Common Shares | A | 1328 | $0.00 - $0.00 | $0 |
2024-01-19 | Roivant Sciences Ltd. | Epperly Melissa B,
(Director) |
A | Common Shares | A | 1207 | $0.00 - $0.00 | $0 |
2024-01-20 | Roivant Sciences Ltd. | Kumar Rakhi
(Chief Accounting Officer) |
F | Common Shares | D | 1506 | $10.35 - $10.35 | $15,587 |
2024-01-20 | Roivant Sciences Ltd. | Gline Matthew
(CEO) |
F | Common Shares | D | 10945 | $10.35 - $10.35 | $113,280 |
2024-01-19 | Roivant Sciences Ltd. | Oren Ilan
(Director) |
A | Common Shares | A | 3366 | $0.00 - $0.00 | $0 |
2024-01-20 | Roivant Sciences Ltd. | Venker Eric
(President & COO) |
F | Common Shares | D | 12377 | $10.35 - $10.35 | $128,101 |
2024-01-02 | Roivant Sciences Ltd. | Ramaswamy Vivek
(AtLeastTenPercentOwner) |
S | Common Shares | D | 3000000 | $11.05 - $11.05 | $33,150,000 |
2023-11-29 | Roivant Sciences Ltd. | Pulik Richard
(CFO) |
J | Common Shares | D | 2360 | $9.13 - $9.13 | $21,546 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |